Table of Contents Author Guidelines Submit a Manuscript
Journal of Pregnancy
Volume 2017, Article ID 8318751, 5 pages
Research Article

Maternal Morbidity in Women with Placenta Previa Managed with Prediction of Morbidly Adherent Placenta by Ultrasonography

1Department of Obstetrics & Gynecology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
2Department of Obstetrics & Gynecology, School of Medicine, Kyorin University, Tokyo, Japan

Correspondence should be addressed to Seishi Furukawa; moc.liamg@ihsies64abiihs

Received 16 November 2016; Revised 19 March 2017; Accepted 3 April 2017; Published 24 April 2017

Academic Editor: Albert Fortuny

Copyright © 2017 Midori Fujisaki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Objective. To determine maternal morbidity in women with placenta previa managed with prediction of morbidly adherent placenta (MAP) by ultrasonography. Methods. A retrospective cohort study was undertaken comprising forty-one women who had placenta previa with or without risk factors for MAP. Women who had all three findings (bladder line interruption, placental lacunae, and absence of the retroplacental clear zone) were regarded as high suspicion for MAP and underwent cesarean section followed by hysterectomy. We attempted placental removal for women having two findings or less. Results. Among 28 women with risk, nine with high suspicion underwent hysterectomy and were diagnosed with MAP. Three of 19 women with two findings or less eventually underwent hysterectomy and were diagnosed with MAP. The sensitivity and positive predictive value for the detection of MAP were 64% and 100%. The pathological severity of MAP was significantly correlated with the cumulative number of findings. There were no cases of MAP among 13 women without risk. There was no difference of blood loss between women with high suspicion and those without risk ( ml versus  ml, resp.; ). Conclusion. Management with prediction of MAP by ultrasonography is useful for obtaining permissible morbidity.